SlideShare a Scribd company logo
1 of 2
Download to read offline
kSORTTM
(kidney Solid Organ Response Test)
is a non-invasive, whole blood derived, molecular
expression assay that can establish an immune risk
index for enhanced post-transplant surveillance of graft
health and immune quiescence in immunosuppressed,
renal transplant patients. In conjunction with standard
clinical care guidelines, kSORTTM
assists in assessing
the overall dynamic immune risk profile of post-renal
transplant patients thereby improving risk stratification
and patient management.
Background
The field of renal transplantation has progressed
considerably in the past half-century largely due to
an improved understanding of the role of the immune
system in allograft rejection, the interpretation of the
molecular mechanisms underlying graft failure, and
better management of immunosuppression. However,
due to the dynamic immune response of transplant
patients, events such as acute rejection (AR) remains
an obstacle occurring in approximately 15%–20% of
patients using the current standard of care.
The current gold standard for detection of graft injury
is an invasive biopsy following an increase in serum
creatinine. However, biopsy histology is subject to
sampling error and increased creatinine is insensitive,
occurring only after graft damage has occurred.
Immune activation can lead to chronic graft injury and
requires cost-intensive care, reduce the quality of life of
patients, and may ultimately result in total graft loss. A
sensitive, specific, and noninvasive test for assessing
the immune risk of post-transplant patients is a critical
and currently unmet need.
Methods
kSORTTM
is a quantitative, real-time PCR (qPCR)
method analyzing the relative expression of a specific,
proprietary gene set in peripheral blood, which has
been shown to play a role in the immune response.
Gene expression of each of the target genes
is measured using TaqMan primer/probes sets
normalized to the expression of 18S ribosomal RNA.
The raw ddCT data generated by kSORTTM
is analyzed
using a proprietary centroid-based algorithm (kSAS),
providing a qualitative Immune Risk Index Score of
HIGH, LOW or INDETERMINATE that can be reported
to clinicians.
Validation of kSORTTM
performance included an
evaluation of accuracy, precision, sensitivity and
specificity. Analytical accuracy analysis demonstrated
substantial correlation, yielding a Cohen’s Kappa of
0.79 (Table 1a) for correlation between ImmucorDx
and The Sarwal lab and 87% agreement between
ImmucorDx results and biopsy results (Table 1b).
Table 1a.
Table 1b.
The assay gives an indeterminate rate of 11%;
sensitivity and specificity are 100% and 96%
respectively after excluding indeterminate samples.
Table 2.
kSORTTM
TECHNICAL BRIEF
Cancer/Infections
Organ Toxicity
Metabolic Disturbance
Acute Cellular
Rejection (ACR)
Antibody Mediated
Rejection (AMR)
Immucor DX
The Sarwal Lab
HIGH IND LOW Total
HIGH 33 4 0 37
IND 0 4 6 10
LOW 0 2 51 53
Total 33 10 57 100
Immucor DX
The Sarwal Lab
AR NO AR Total
HIGH 26 2 28
IND 2 7 9
LOW 0 47 47
Total 28 56 84
Agreegment Rate 87%
IND Rate 11%
Sensitivity 100%
Specificity 96%
301 Michigan St NE, Suite 580
Grand Rapids, MI 49503
800.363.5915
www.immucor.com/DX
INJURY
Reversible
3 months 2 months 1 month
kSORTTM
Creatinine
Biopsy
Irreversible
POST TRANSPLANT
SURVEILLANCE
301 Michigan St NE, Suite 580
Grand Rapids, MI 49503
800.363.5915
www.immucor.com/DX
Ordering and Shipping Instructions
Peripheral blood specimens for kSORTTM
are collected in PAXgene Blood
RNA Tubes and sent to IMMUCOR DX, Grand Rapids, MI, USA along with the
appropriate test requisition, patient and billing information. The PAXgene tube
protects RNA from degradation thereby allowing for prolonged storage and
transportation of the specimen. A PAXgene specimen is stable for 3 days at
15-25oC, 5 days at 2-8oC, and up to 8 years at <-20oC. The standard return
shipping for kSORTTM kits is 2 business days. Contact IMMUCOR DX for
ordering supplies and customer support at 1-800-363-5915.
Turnaround time and Reporting
Turnaround time (TAT) is 3 business days from receipt at IMMUCOR DX.
Reports will
be sent by fax to the ordering physician.
CPT Codes and Description
CPT 81599 Unlisted multianalyte assay with algorithmic analysis
CPT 86849 Unlisted immunology procedure
The CPT codes provided are for general informational purposes only. CPT coding is the
sole responsibility of the billing party. Questions regarding coding should be addressed
to your local Medicare carrier. Immucor assumes no responsibility for billing errors due to
reliance on the CPT codes illustrated in this material.
Analytical Performance of the Kidney Solid Organ Response Test (kSORTTM
)
Namrata Bhatia (MPH)1
, Jody Thurston MT(ASCP)2
, Tiffany Roberts, PhD2. 1
953 Indiana
St, San Francisco, CA 94107; 2301 Michigan St. NE STE 580, Grand Rapids, MI 49503

More Related Content

What's hot

Noncoding RNAs in Cardiovascular Disease – Potential as Biomarkers and More
Noncoding RNAs in Cardiovascular Disease – Potential as Biomarkers and MoreNoncoding RNAs in Cardiovascular Disease – Potential as Biomarkers and More
Noncoding RNAs in Cardiovascular Disease – Potential as Biomarkers and MoreQIAGEN
 
Poster Summary Presentation FINAL
Poster Summary Presentation FINALPoster Summary Presentation FINAL
Poster Summary Presentation FINALWilliam Andrews
 
A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...
A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...
A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...Thermo Fisher Scientific
 
Van criekinge next_generation_epigenetic_profling_vlille
Van criekinge next_generation_epigenetic_profling_vlilleVan criekinge next_generation_epigenetic_profling_vlille
Van criekinge next_generation_epigenetic_profling_vlilleProf. Wim Van Criekinge
 
Juliane Carvalho Cancer Biology Presentation
Juliane Carvalho Cancer Biology PresentationJuliane Carvalho Cancer Biology Presentation
Juliane Carvalho Cancer Biology PresentationBrazilPharmaNews.com
 
Sequencing the circulating and infiltrating T-cell repertoire on the Ion S5TM
Sequencing the circulating and infiltrating T-cell repertoire on the Ion S5TMSequencing the circulating and infiltrating T-cell repertoire on the Ion S5TM
Sequencing the circulating and infiltrating T-cell repertoire on the Ion S5TMThermo Fisher Scientific
 
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...Thermo Fisher Scientific
 
Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...
Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...
Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...Thermo Fisher Scientific
 
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCRMultiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCRThermo Fisher Scientific
 
EGFR -TkI resistance pathways
EGFR -TkI resistance pathways  EGFR -TkI resistance pathways
EGFR -TkI resistance pathways Maria Jubran
 
2014 03 28_next_generation_epigenetic_profling_v_les_epigenetica_vweb
2014 03 28_next_generation_epigenetic_profling_v_les_epigenetica_vweb2014 03 28_next_generation_epigenetic_profling_v_les_epigenetica_vweb
2014 03 28_next_generation_epigenetic_profling_v_les_epigenetica_vwebProf. Wim Van Criekinge
 
miRNA profiling from blood challenges and recommendations - Download the article
miRNA profiling from blood challenges and recommendations - Download the articlemiRNA profiling from blood challenges and recommendations - Download the article
miRNA profiling from blood challenges and recommendations - Download the articleQIAGEN
 
High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...
High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...
High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...Thermo Fisher Scientific
 
Orthogonal Verification of Oncomine cfDNA Data with Digital PCR Using TaqMan ...
Orthogonal Verification of Oncomine cfDNA Data with Digital PCR Using TaqMan ...Orthogonal Verification of Oncomine cfDNA Data with Digital PCR Using TaqMan ...
Orthogonal Verification of Oncomine cfDNA Data with Digital PCR Using TaqMan ...Thermo Fisher Scientific
 
Analytical performance of a novel next generation sequencing assay for Myeloi...
Analytical performance of a novel next generation sequencing assay for Myeloi...Analytical performance of a novel next generation sequencing assay for Myeloi...
Analytical performance of a novel next generation sequencing assay for Myeloi...Thermo Fisher Scientific
 
Iverson Genetic Testing Client Presentation
Iverson Genetic Testing Client PresentationIverson Genetic Testing Client Presentation
Iverson Genetic Testing Client Presentationvincentlecca
 
Iverson Genetic Testing Client Presentation
Iverson Genetic Testing Client PresentationIverson Genetic Testing Client Presentation
Iverson Genetic Testing Client Presentationvincentlecca
 

What's hot (20)

Noncoding RNAs in Cardiovascular Disease – Potential as Biomarkers and More
Noncoding RNAs in Cardiovascular Disease – Potential as Biomarkers and MoreNoncoding RNAs in Cardiovascular Disease – Potential as Biomarkers and More
Noncoding RNAs in Cardiovascular Disease – Potential as Biomarkers and More
 
Poster Summary Presentation FINAL
Poster Summary Presentation FINALPoster Summary Presentation FINAL
Poster Summary Presentation FINAL
 
A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...
A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...
A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...
 
Van criekinge next_generation_epigenetic_profling_vlille
Van criekinge next_generation_epigenetic_profling_vlilleVan criekinge next_generation_epigenetic_profling_vlille
Van criekinge next_generation_epigenetic_profling_vlille
 
Thesis - Abstract
Thesis - AbstractThesis - Abstract
Thesis - Abstract
 
Tessa Poster for IP
Tessa Poster for IP Tessa Poster for IP
Tessa Poster for IP
 
Juliane Carvalho Cancer Biology Presentation
Juliane Carvalho Cancer Biology PresentationJuliane Carvalho Cancer Biology Presentation
Juliane Carvalho Cancer Biology Presentation
 
Sequencing the circulating and infiltrating T-cell repertoire on the Ion S5TM
Sequencing the circulating and infiltrating T-cell repertoire on the Ion S5TMSequencing the circulating and infiltrating T-cell repertoire on the Ion S5TM
Sequencing the circulating and infiltrating T-cell repertoire on the Ion S5TM
 
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
 
Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...
Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...
Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...
 
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCRMultiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
 
EGFR -TkI resistance pathways
EGFR -TkI resistance pathways  EGFR -TkI resistance pathways
EGFR -TkI resistance pathways
 
2014 03 28_next_generation_epigenetic_profling_v_les_epigenetica_vweb
2014 03 28_next_generation_epigenetic_profling_v_les_epigenetica_vweb2014 03 28_next_generation_epigenetic_profling_v_les_epigenetica_vweb
2014 03 28_next_generation_epigenetic_profling_v_les_epigenetica_vweb
 
Pp adna epi_tect
Pp adna epi_tectPp adna epi_tect
Pp adna epi_tect
 
miRNA profiling from blood challenges and recommendations - Download the article
miRNA profiling from blood challenges and recommendations - Download the articlemiRNA profiling from blood challenges and recommendations - Download the article
miRNA profiling from blood challenges and recommendations - Download the article
 
High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...
High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...
High Sensitivity Sanger Sequencing for Minor Indel Detection and Characteriza...
 
Orthogonal Verification of Oncomine cfDNA Data with Digital PCR Using TaqMan ...
Orthogonal Verification of Oncomine cfDNA Data with Digital PCR Using TaqMan ...Orthogonal Verification of Oncomine cfDNA Data with Digital PCR Using TaqMan ...
Orthogonal Verification of Oncomine cfDNA Data with Digital PCR Using TaqMan ...
 
Analytical performance of a novel next generation sequencing assay for Myeloi...
Analytical performance of a novel next generation sequencing assay for Myeloi...Analytical performance of a novel next generation sequencing assay for Myeloi...
Analytical performance of a novel next generation sequencing assay for Myeloi...
 
Iverson Genetic Testing Client Presentation
Iverson Genetic Testing Client PresentationIverson Genetic Testing Client Presentation
Iverson Genetic Testing Client Presentation
 
Iverson Genetic Testing Client Presentation
Iverson Genetic Testing Client PresentationIverson Genetic Testing Client Presentation
Iverson Genetic Testing Client Presentation
 

Viewers also liked (6)

GSA LETTER
GSA LETTERGSA LETTER
GSA LETTER
 
ΑΡΚΑΣ Σταυρόλεξα
ΑΡΚΑΣ ΣταυρόλεξαΑΡΚΑΣ Σταυρόλεξα
ΑΡΚΑΣ Σταυρόλεξα
 
Matematica estas ahi
Matematica estas ahiMatematica estas ahi
Matematica estas ahi
 
Agenda
AgendaAgenda
Agenda
 
腫瘤是一種氣結
腫瘤是一種氣結腫瘤是一種氣結
腫瘤是一種氣結
 
Diapos
DiaposDiapos
Diapos
 

Similar to IMM_749_kSORT_TechnicalBrief_2016_Final_NoCrops

IMM_752_kSORT_Whitepaper_2016_revfinal_NoCrops
IMM_752_kSORT_Whitepaper_2016_revfinal_NoCropsIMM_752_kSORT_Whitepaper_2016_revfinal_NoCrops
IMM_752_kSORT_Whitepaper_2016_revfinal_NoCropsKevin Jaglinski
 
Q biomarkersomaticmutation
Q biomarkersomaticmutationQ biomarkersomaticmutation
Q biomarkersomaticmutationElsa von Licy
 
Rapid and accurate Cancer somatic mutation profiling with the qBiomarker Soma...
Rapid and accurate Cancer somatic mutation profiling with the qBiomarker Soma...Rapid and accurate Cancer somatic mutation profiling with the qBiomarker Soma...
Rapid and accurate Cancer somatic mutation profiling with the qBiomarker Soma...QIAGEN
 
NSCLC: diagnóstico molecular, pronóstico y seguimiento; CTC
NSCLC: diagnóstico molecular, pronóstico y seguimiento; CTCNSCLC: diagnóstico molecular, pronóstico y seguimiento; CTC
NSCLC: diagnóstico molecular, pronóstico y seguimiento; CTCMauricio Lema
 
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...Affymetrix
 
Sequencing the Human TCRβ Repertoire on the Ion S5TM
Sequencing the Human TCRβ Repertoire on the Ion S5TMSequencing the Human TCRβ Repertoire on the Ion S5TM
Sequencing the Human TCRβ Repertoire on the Ion S5TMThermo Fisher Scientific
 
2016-ESMO_Arrieta_Barrera_Gustafson Liquid Biopsy
2016-ESMO_Arrieta_Barrera_Gustafson Liquid Biopsy2016-ESMO_Arrieta_Barrera_Gustafson Liquid Biopsy
2016-ESMO_Arrieta_Barrera_Gustafson Liquid BiopsyBret Gustafson
 
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...Thermo Fisher Scientific
 
Circ ldlrad3 regulates cell proliferation, migration and invasion of pancreat...
Circ ldlrad3 regulates cell proliferation, migration and invasion of pancreat...Circ ldlrad3 regulates cell proliferation, migration and invasion of pancreat...
Circ ldlrad3 regulates cell proliferation, migration and invasion of pancreat...Clinical Surgery Research Communications
 
Amany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany Elshamy
 
Pcr array whitepaper_app
Pcr array whitepaper_appPcr array whitepaper_app
Pcr array whitepaper_appElsa von Licy
 
Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...
Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...
Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...dr.Ihsan alsaimary
 
Kshivets O. Cancer, Computer Sciences and Alive Supersystems
Kshivets O. Cancer, Computer Sciences and Alive SupersystemsKshivets O. Cancer, Computer Sciences and Alive Supersystems
Kshivets O. Cancer, Computer Sciences and Alive SupersystemsOleg Kshivets
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...semualkaira
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...semualkaira
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...semualkaira
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...semualkaira
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...semualkaira
 

Similar to IMM_749_kSORT_TechnicalBrief_2016_Final_NoCrops (20)

IMM_752_kSORT_Whitepaper_2016_revfinal_NoCrops
IMM_752_kSORT_Whitepaper_2016_revfinal_NoCropsIMM_752_kSORT_Whitepaper_2016_revfinal_NoCrops
IMM_752_kSORT_Whitepaper_2016_revfinal_NoCrops
 
Q biomarkersomaticmutation
Q biomarkersomaticmutationQ biomarkersomaticmutation
Q biomarkersomaticmutation
 
Rapid and accurate Cancer somatic mutation profiling with the qBiomarker Soma...
Rapid and accurate Cancer somatic mutation profiling with the qBiomarker Soma...Rapid and accurate Cancer somatic mutation profiling with the qBiomarker Soma...
Rapid and accurate Cancer somatic mutation profiling with the qBiomarker Soma...
 
NSCLC: diagnóstico molecular, pronóstico y seguimiento; CTC
NSCLC: diagnóstico molecular, pronóstico y seguimiento; CTCNSCLC: diagnóstico molecular, pronóstico y seguimiento; CTC
NSCLC: diagnóstico molecular, pronóstico y seguimiento; CTC
 
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
Use of Affymetrix Arrays (GeneChip® Human Transcriptome 2.0 Array and Cytosca...
 
Chims poster
Chims posterChims poster
Chims poster
 
Sequencing the Human TCRβ Repertoire on the Ion S5TM
Sequencing the Human TCRβ Repertoire on the Ion S5TMSequencing the Human TCRβ Repertoire on the Ion S5TM
Sequencing the Human TCRβ Repertoire on the Ion S5TM
 
2016-ESMO_Arrieta_Barrera_Gustafson Liquid Biopsy
2016-ESMO_Arrieta_Barrera_Gustafson Liquid Biopsy2016-ESMO_Arrieta_Barrera_Gustafson Liquid Biopsy
2016-ESMO_Arrieta_Barrera_Gustafson Liquid Biopsy
 
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
Clinical Validation of an NGS-based (CE-IVD) Kit for Targeted Detection of Ge...
 
Circ ldlrad3 regulates cell proliferation, migration and invasion of pancreat...
Circ ldlrad3 regulates cell proliferation, migration and invasion of pancreat...Circ ldlrad3 regulates cell proliferation, migration and invasion of pancreat...
Circ ldlrad3 regulates cell proliferation, migration and invasion of pancreat...
 
Amany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide results
 
Pcr array whitepaper_app
Pcr array whitepaper_appPcr array whitepaper_app
Pcr array whitepaper_app
 
Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...
Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...
Assessment of immunomolecular_expression_and_prognostic_role_of_tlr7_among_pa...
 
IPCR for cancer.pdf
IPCR for cancer.pdfIPCR for cancer.pdf
IPCR for cancer.pdf
 
Kshivets O. Cancer, Computer Sciences and Alive Supersystems
Kshivets O. Cancer, Computer Sciences and Alive SupersystemsKshivets O. Cancer, Computer Sciences and Alive Supersystems
Kshivets O. Cancer, Computer Sciences and Alive Supersystems
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
 
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
The Coagulation Profile Monitoring of COVID-19 Patients with Standard and Vis...
 

More from Kevin Jaglinski

Molecular and Functional Immune Assays as Non-Invasive Diagnostic Tools to As...
Molecular and Functional Immune Assays as Non-Invasive Diagnostic Tools to As...Molecular and Functional Immune Assays as Non-Invasive Diagnostic Tools to As...
Molecular and Functional Immune Assays as Non-Invasive Diagnostic Tools to As...Kevin Jaglinski
 
A Model to Explore the Potential Budget Impact of a Novel Screening Tool for ...
A Model to Explore the Potential Budget Impact of a Novel Screening Tool for ...A Model to Explore the Potential Budget Impact of a Novel Screening Tool for ...
A Model to Explore the Potential Budget Impact of a Novel Screening Tool for ...Kevin Jaglinski
 
A Non-Invasive Blood Transcriptional Assay, Ksort, Monitors Alloimmune Respon...
A Non-Invasive Blood Transcriptional Assay, Ksort, Monitors Alloimmune Respon...A Non-Invasive Blood Transcriptional Assay, Ksort, Monitors Alloimmune Respon...
A Non-Invasive Blood Transcriptional Assay, Ksort, Monitors Alloimmune Respon...Kevin Jaglinski
 
Press Release - kSORT Launch vF
Press Release - kSORT Launch vFPress Release - kSORT Launch vF
Press Release - kSORT Launch vFKevin Jaglinski
 
IMM_683_kSORT_ISPOR_Poster_rebrand2015_v2
IMM_683_kSORT_ISPOR_Poster_rebrand2015_v2IMM_683_kSORT_ISPOR_Poster_rebrand2015_v2
IMM_683_kSORT_ISPOR_Poster_rebrand2015_v2Kevin Jaglinski
 
The kSORT Assay to Detect Renal Transplant Patients at High Risk
The kSORT Assay to Detect Renal Transplant Patients at High RiskThe kSORT Assay to Detect Renal Transplant Patients at High Risk
The kSORT Assay to Detect Renal Transplant Patients at High RiskKevin Jaglinski
 
A_Rapid_Noninvasive_Assay_for_the_Detection_of 2013 96_17
A_Rapid_Noninvasive_Assay_for_the_Detection_of 2013 96_17A_Rapid_Noninvasive_Assay_for_the_Detection_of 2013 96_17
A_Rapid_Noninvasive_Assay_for_the_Detection_of 2013 96_17Kevin Jaglinski
 
A Peripheral Blood Diagnostic Test for Acute Rejection in renal transplantati...
A Peripheral Blood Diagnostic Test for Acute Rejection in renal transplantati...A Peripheral Blood Diagnostic Test for Acute Rejection in renal transplantati...
A Peripheral Blood Diagnostic Test for Acute Rejection in renal transplantati...Kevin Jaglinski
 
A common rejection module (CRM) for acute rejection across multiple organs
A common rejection module (CRM) for acute rejection across multiple organsA common rejection module (CRM) for acute rejection across multiple organs
A common rejection module (CRM) for acute rejection across multiple organsKevin Jaglinski
 
The kSORT assay to detect renal transplant patients at risk for acute rejecti...
The kSORT assay to detect renal transplant patients at risk for acute rejecti...The kSORT assay to detect renal transplant patients at risk for acute rejecti...
The kSORT assay to detect renal transplant patients at risk for acute rejecti...Kevin Jaglinski
 
Introducing kSORT (kidney Solid Organ Response Test)
Introducing kSORT (kidney Solid Organ Response Test)Introducing kSORT (kidney Solid Organ Response Test)
Introducing kSORT (kidney Solid Organ Response Test)Kevin Jaglinski
 
Novel tools for immune quiecense monitoring in kidney transplanation poster a...
Novel tools for immune quiecense monitoring in kidney transplanation poster a...Novel tools for immune quiecense monitoring in kidney transplanation poster a...
Novel tools for immune quiecense monitoring in kidney transplanation poster a...Kevin Jaglinski
 
Organ-i World Transplant Congress Soild Organ Rejection Test (k-SORT)
Organ-i World Transplant Congress Soild Organ Rejection Test (k-SORT)Organ-i World Transplant Congress Soild Organ Rejection Test (k-SORT)
Organ-i World Transplant Congress Soild Organ Rejection Test (k-SORT)Kevin Jaglinski
 
Comparison of blood collection and testing models
Comparison of blood collection and testing modelsComparison of blood collection and testing models
Comparison of blood collection and testing modelsKevin Jaglinski
 

More from Kevin Jaglinski (15)

Molecular and Functional Immune Assays as Non-Invasive Diagnostic Tools to As...
Molecular and Functional Immune Assays as Non-Invasive Diagnostic Tools to As...Molecular and Functional Immune Assays as Non-Invasive Diagnostic Tools to As...
Molecular and Functional Immune Assays as Non-Invasive Diagnostic Tools to As...
 
A Model to Explore the Potential Budget Impact of a Novel Screening Tool for ...
A Model to Explore the Potential Budget Impact of a Novel Screening Tool for ...A Model to Explore the Potential Budget Impact of a Novel Screening Tool for ...
A Model to Explore the Potential Budget Impact of a Novel Screening Tool for ...
 
A Non-Invasive Blood Transcriptional Assay, Ksort, Monitors Alloimmune Respon...
A Non-Invasive Blood Transcriptional Assay, Ksort, Monitors Alloimmune Respon...A Non-Invasive Blood Transcriptional Assay, Ksort, Monitors Alloimmune Respon...
A Non-Invasive Blood Transcriptional Assay, Ksort, Monitors Alloimmune Respon...
 
IMMUCOR DX PPT
IMMUCOR DX PPTIMMUCOR DX PPT
IMMUCOR DX PPT
 
Press Release - kSORT Launch vF
Press Release - kSORT Launch vFPress Release - kSORT Launch vF
Press Release - kSORT Launch vF
 
IMM_683_kSORT_ISPOR_Poster_rebrand2015_v2
IMM_683_kSORT_ISPOR_Poster_rebrand2015_v2IMM_683_kSORT_ISPOR_Poster_rebrand2015_v2
IMM_683_kSORT_ISPOR_Poster_rebrand2015_v2
 
The kSORT Assay to Detect Renal Transplant Patients at High Risk
The kSORT Assay to Detect Renal Transplant Patients at High RiskThe kSORT Assay to Detect Renal Transplant Patients at High Risk
The kSORT Assay to Detect Renal Transplant Patients at High Risk
 
A_Rapid_Noninvasive_Assay_for_the_Detection_of 2013 96_17
A_Rapid_Noninvasive_Assay_for_the_Detection_of 2013 96_17A_Rapid_Noninvasive_Assay_for_the_Detection_of 2013 96_17
A_Rapid_Noninvasive_Assay_for_the_Detection_of 2013 96_17
 
A Peripheral Blood Diagnostic Test for Acute Rejection in renal transplantati...
A Peripheral Blood Diagnostic Test for Acute Rejection in renal transplantati...A Peripheral Blood Diagnostic Test for Acute Rejection in renal transplantati...
A Peripheral Blood Diagnostic Test for Acute Rejection in renal transplantati...
 
A common rejection module (CRM) for acute rejection across multiple organs
A common rejection module (CRM) for acute rejection across multiple organsA common rejection module (CRM) for acute rejection across multiple organs
A common rejection module (CRM) for acute rejection across multiple organs
 
The kSORT assay to detect renal transplant patients at risk for acute rejecti...
The kSORT assay to detect renal transplant patients at risk for acute rejecti...The kSORT assay to detect renal transplant patients at risk for acute rejecti...
The kSORT assay to detect renal transplant patients at risk for acute rejecti...
 
Introducing kSORT (kidney Solid Organ Response Test)
Introducing kSORT (kidney Solid Organ Response Test)Introducing kSORT (kidney Solid Organ Response Test)
Introducing kSORT (kidney Solid Organ Response Test)
 
Novel tools for immune quiecense monitoring in kidney transplanation poster a...
Novel tools for immune quiecense monitoring in kidney transplanation poster a...Novel tools for immune quiecense monitoring in kidney transplanation poster a...
Novel tools for immune quiecense monitoring in kidney transplanation poster a...
 
Organ-i World Transplant Congress Soild Organ Rejection Test (k-SORT)
Organ-i World Transplant Congress Soild Organ Rejection Test (k-SORT)Organ-i World Transplant Congress Soild Organ Rejection Test (k-SORT)
Organ-i World Transplant Congress Soild Organ Rejection Test (k-SORT)
 
Comparison of blood collection and testing models
Comparison of blood collection and testing modelsComparison of blood collection and testing models
Comparison of blood collection and testing models
 

IMM_749_kSORT_TechnicalBrief_2016_Final_NoCrops

  • 1. kSORTTM (kidney Solid Organ Response Test) is a non-invasive, whole blood derived, molecular expression assay that can establish an immune risk index for enhanced post-transplant surveillance of graft health and immune quiescence in immunosuppressed, renal transplant patients. In conjunction with standard clinical care guidelines, kSORTTM assists in assessing the overall dynamic immune risk profile of post-renal transplant patients thereby improving risk stratification and patient management. Background The field of renal transplantation has progressed considerably in the past half-century largely due to an improved understanding of the role of the immune system in allograft rejection, the interpretation of the molecular mechanisms underlying graft failure, and better management of immunosuppression. However, due to the dynamic immune response of transplant patients, events such as acute rejection (AR) remains an obstacle occurring in approximately 15%–20% of patients using the current standard of care. The current gold standard for detection of graft injury is an invasive biopsy following an increase in serum creatinine. However, biopsy histology is subject to sampling error and increased creatinine is insensitive, occurring only after graft damage has occurred. Immune activation can lead to chronic graft injury and requires cost-intensive care, reduce the quality of life of patients, and may ultimately result in total graft loss. A sensitive, specific, and noninvasive test for assessing the immune risk of post-transplant patients is a critical and currently unmet need. Methods kSORTTM is a quantitative, real-time PCR (qPCR) method analyzing the relative expression of a specific, proprietary gene set in peripheral blood, which has been shown to play a role in the immune response. Gene expression of each of the target genes is measured using TaqMan primer/probes sets normalized to the expression of 18S ribosomal RNA. The raw ddCT data generated by kSORTTM is analyzed using a proprietary centroid-based algorithm (kSAS), providing a qualitative Immune Risk Index Score of HIGH, LOW or INDETERMINATE that can be reported to clinicians. Validation of kSORTTM performance included an evaluation of accuracy, precision, sensitivity and specificity. Analytical accuracy analysis demonstrated substantial correlation, yielding a Cohen’s Kappa of 0.79 (Table 1a) for correlation between ImmucorDx and The Sarwal lab and 87% agreement between ImmucorDx results and biopsy results (Table 1b). Table 1a. Table 1b. The assay gives an indeterminate rate of 11%; sensitivity and specificity are 100% and 96% respectively after excluding indeterminate samples. Table 2. kSORTTM TECHNICAL BRIEF Cancer/Infections Organ Toxicity Metabolic Disturbance Acute Cellular Rejection (ACR) Antibody Mediated Rejection (AMR) Immucor DX The Sarwal Lab HIGH IND LOW Total HIGH 33 4 0 37 IND 0 4 6 10 LOW 0 2 51 53 Total 33 10 57 100 Immucor DX The Sarwal Lab AR NO AR Total HIGH 26 2 28 IND 2 7 9 LOW 0 47 47 Total 28 56 84 Agreegment Rate 87% IND Rate 11% Sensitivity 100% Specificity 96% 301 Michigan St NE, Suite 580 Grand Rapids, MI 49503 800.363.5915 www.immucor.com/DX INJURY Reversible 3 months 2 months 1 month kSORTTM Creatinine Biopsy Irreversible POST TRANSPLANT SURVEILLANCE
  • 2. 301 Michigan St NE, Suite 580 Grand Rapids, MI 49503 800.363.5915 www.immucor.com/DX Ordering and Shipping Instructions Peripheral blood specimens for kSORTTM are collected in PAXgene Blood RNA Tubes and sent to IMMUCOR DX, Grand Rapids, MI, USA along with the appropriate test requisition, patient and billing information. The PAXgene tube protects RNA from degradation thereby allowing for prolonged storage and transportation of the specimen. A PAXgene specimen is stable for 3 days at 15-25oC, 5 days at 2-8oC, and up to 8 years at <-20oC. The standard return shipping for kSORTTM kits is 2 business days. Contact IMMUCOR DX for ordering supplies and customer support at 1-800-363-5915. Turnaround time and Reporting Turnaround time (TAT) is 3 business days from receipt at IMMUCOR DX. Reports will be sent by fax to the ordering physician. CPT Codes and Description CPT 81599 Unlisted multianalyte assay with algorithmic analysis CPT 86849 Unlisted immunology procedure The CPT codes provided are for general informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Immucor assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material. Analytical Performance of the Kidney Solid Organ Response Test (kSORTTM ) Namrata Bhatia (MPH)1 , Jody Thurston MT(ASCP)2 , Tiffany Roberts, PhD2. 1 953 Indiana St, San Francisco, CA 94107; 2301 Michigan St. NE STE 580, Grand Rapids, MI 49503